Skip to content

Cardiovascular Imaging Registry of Canada

Cardiovascular Imaging Registry of Canada

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04367220
Acronym
CIROC
Enrollment
45000
Registered
2020-04-29
Start date
2014-08-31
Completion date
2030-08-31
Last updated
2024-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Brief summary

A multi-site, multi-modality prospective observational clinical outcomes study focussed on the development of phenotype-dirven risk prediction modelling in patients with known or suspected cardiovascular disease.

Detailed description

The Cardiovascular Imaging Registry of Canada (CIROC) was conceived to provide a common standardized architecture for the collection of clinically reported imaging biomarkers, demographic information, resource utilization and clinical outcomes among patients referred to non-invasive cardiac imaging. The Registry was designed to assess the feasibility of implementing personalized care strategies through automated high quality data collection and patient engagement. The CIROC Registry was launched with inaugural focus on Cardiac MRI base phenotyping, however has evolved to encompass cardiac CTA and echocardiography. Clinically referred patients are engaged by automated, tablet-based tools to collect informed consent and deploy standardized patient health assessments. Standardized reporting of disease features are captured using bespoke reporting tools. All patients are prospectively followed for a period of 10-years using linkage to administrative health data, inclusive of ICD-coded events, laboratory test results, ECG and vital statistics.

Interventions

DIAGNOSTIC_TESTDiagnostic testing performed as per routine care

Sponsors

Alberta Health services
CollaboratorOTHER
University of Calgary
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients referred for hospital-based cardiac imaging services

Exclusion criteria

* Failure or provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Major adverse cardiovascular outcomes (MACE)2024Composite of all-cause death, heart failure admission, myocardial infarction, heart transplantation or LVAD, Stroke or TIA
Malignant arrhythmic events2024Composite of sudden cardiac death or appropriate ICD shock
Heart failure events2024Composite of heart failure admission, death or need for transplantation / LVAD
Atrial arrhythmic events2024Occurrence of atrial fibrillation / atrial flutter (documented by 12-lead ECG or Holter monitor)
All-cause mortality2024Death based on Vital Statistics Alberta and In-hospital coded death

Countries

Canada

Contacts

Primary ContactJames White
jawhit@ucalgary.ca403-944-2805
Backup ContactSandra Rivest
sandra.rivest@ahs.ca403-944-1961

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026